HETEROLOGOUS EXPRESSION OF SIX KEY ENZYMES INVOLVED IN THE PRODUCTION OF ARTEMISININ PRECURSORS IN SACCHAROMYCES CEREVISIAE BY4741
Malaria, one of the infectious diseases that still contributes to a very large global mortality rate per year, which is around 435,000 people with the number of cases reaching 219 million in 2017 spread across 87 countries. In Indonesia, the total number of malaria cases recorded in 2019 there we...
Saved in:
Main Author: | |
---|---|
Format: | Theses |
Language: | Indonesia |
Online Access: | https://digilib.itb.ac.id/gdl/view/52080 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
Summary: | Malaria, one of the infectious diseases that still contributes to a very large global
mortality rate per year, which is around 435,000 people with the number of cases
reaching 219 million in 2017 spread across 87 countries. In Indonesia, the total
number of malaria cases recorded in 2019 there were 250,644 cases. Artemisinin
combination therapy (ACT) is the latest method suggested by WHO for malaria
treatment. Regrettably, the amount of artemisinin produced naturally is very low
therefore scientists are challenged to find a new way to overcome this problem.
In this research, we performed heterologous expression of six key enzymes that
involved in the artemisinin precursor biosynthesis namely farnesyl pyrophosphate
synthase (FPS), amorphadiene synthase (ADS), cytochrome P450
monooxygenase (CYP71AV1), cytochrome P450 reductase (CPR), artemisinic
aldehyde ?11 (13) reductase (DBR2), and artemisinic aldehyde dehydrogenase
(ALDH1) in Saccharomyces cerevisiae BY4741. The expression of these key
enzymes is expected to change the metabolic pathways in yeast to produce a
precursor metabolite of semi-synthetic artemisinin, namely artemisinic acid. This
research was conducted using four recombinant plasmids as gene carriers, which
are pBEVY-GL_fps, pBEVY-GU_ads_cyp71av1, pESC-HIS_cpr, and pBEVY-
L_dbr2_aldh1. The transformation process was carried out by the electroporation
method on S. cerevisiae BY4741 wildtype. Confirmation was carried out using
auxotrophs selection media and PCR colony to prove that all plasmids had
successfully transformed. Furthermore, the transformant were expressed then
tested by being given a treatment that is induced by using glucose and galactose as
carbon sources to compare the metabolite results. The final results prove that S.
cerevisiae BY4741 transformant can produce metabolites presumed one of them
to be artemisinic acid which is the final precursor before the formation of semisynthetic artemisinin with presences of galactose as an inducer compared to
glucose.
|
---|